Status report
Get it in writing
The official USPTO status record for XCELL BMF, serial 97680273, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
XCELL BMFSerial 97680273 · Principal Register
Dead · Refused
Owner: APEX Biologix, LLC
Class 010 -
Filed Nov 16, 2022
The record shows that the mark “XCELL BMF” is dead; it was abandoned because the owner, APEX Biologix, LLC, did not file a Statement of Use or an extension request after the Notice of Allowance. The mark was filed on November 16, 2022 and was published for opposition on October 3, 2023, with a Notice of Allowance issued on November 28, 2023. The goods listed are medical apparatus and supplies for stem‑cell regeneration, blood filtration, luer lock needles, diagnostic instruments, gloves, and related sterile items. A similar name would raise the closest concern in the same medical device and diagnostic instrument area. This record does not give the owner control over every use of the wording; it only covers the specific goods listed. The prosecution history shows a standard sequence of extension requests and eventual abandonment, with no enforcement actions recorded. The last meaningful event was the abandonment notice on October 1, 2025. For someone considering a similar name, the record suggests a meaningful concern in the medical device field, but the mark is no longer active.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.